Phase I – Bioequivalence

302 trials 14 recruiting

Filter these 302 trials by condition, country, sponsor and more.

Open in Search →

Bioequivalence of Oxazepam 10 mg Orodispersible Tablets Versus Seresta® 10 mg Tablets in Healthy Subjects Ended

2022-501134-35-00 No medical condition is being investigated. This is a c 2022-10-26
Comparative Bioavailability of Nilotinib 200 mg Hard Capsules in Healthy Subjects. Ended

2022-501325-20-00 Primary Philadelphia-chromosome positive leukemia cells 2022-10-06
Bioequivalence clinical trial of two formulations of Pregabalin 300 mg. Ended

2022-501160-18-00 Healthy volunteers 2022-09-22
A research study investigating how semaglutide and dapagliflozin act in your body when dosed in one tablet Ended

2022-500007-52-00 Diabetes Mellitus, Type 2 2022-06-14
A study to compare Onivyde manufactured at two different production sites in adult participants with advanced cancer in the pancreas Ended

2024-516760-28-00 Metastatic Pancreatic Adenocarcinoma 2022-05-04
Phase Ib of Cyclophosphamide, Pomalidomide, Dexamethasone and Daratumumab (CPD-DARA) in patients with relapsed/refractory multiple myeloma. … Ended

2024-516945-37-00 Relapsed/ refractory multiple myeloma 2021-11-04
Bioequivalence of Eltrombopag 25 mg Film-Coated Tablets in Healthy Subjects Under Fasting Conditions. Ended

2023-504468-41-00 No medical condition
Bioequivalence study of a proposed biosimilar insulin glargine U300 with Toujeo® Ended

2023-504509-36-00 Type 1 Diabetes Mellitus
Comparative Bioavailability of Diclofenac 2.32% Gel in Healthy Adult Subjects Ended

2023-507428-21-00 No medical condition.
A study to investigate the similarity of two different Tiotropium inhalers in healthy volunteers. Ended

2023-509025-41-00 No therapeutic indication in the current trial with hea
Bioequivalence of Lenvatinib 10 mg Capsules versus Lenvima® 10 mg Capsules in Healthy Participants Under Fed Conditions Ended

2024-512912-23-00 No medical condition
A study to investigate the similarity of two different Tiotropium inhalers in healthy volunteers. Ended

2024-515876-10-00 No therapeutic indication in the present bioequivalence
Comparative Bioavailability of Teriflunomide 14 mg Film-Coated Tablets: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, … Ended

2024-516401-23-00 No medical condition.
Single dose oral bioequivalence study of Cladribine 10 mg Tablets and Mavenclad® 10 mg tablets (Cladribine) in healthy adult human subjects … Ended

2025-522252-74-00 No therapeutic indication in the current trial with hea